Celldex Therapeutics, Inc. (CLDX) Form 8-K — Jul 15, 2026

$CLDXForm 8-KItems 5.02, 9.01Filed Jul 15, 2026, 4:07 PM ET0001104659-26-083880Original filing

Celldex Therapeutics announced that Sam Martin, Senior Vice President and Chief Financial Officer, plans to retire effective on or about March 31, 2027. Mr. Martin, who has served as CFO since July 2017 and joined the company in April 2009, notified the company of his decision on July 10, 2026. The company has initiated a search for a new Chief Financial Officer.

Price after filing

1 day: -7.6%7 days: -9.2%30 days: +11.2%

Close on the filing date to close N calendar days later (from $38.31). Historical, not a forecast.

AI analysis

Red flags1 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.